Moreover, drugs targeting ADAM17 from the DrugBank database showed eight small molecule compounds targeted only for ADAM17, demonstrating the therapeutic significance of targeting ADAM17 for both the prevention of tumor progression and SARS-CoV-2 attacking in immune implications. The gene discussed is ADAM17; the disease is neoplasm.